Clinical Trials · NCT01794143
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- GRADE Study Group
- Enrollment
- 7,850
- Start date
- May 2013
- Locations
- 36 sites, United States
- Primary endpoint
- Time to HbA1c>=7%, While Receiving Metformin and the Randomly Assigned Glucose-lowering Study Medication